Logo

Japanese Clinical Study of DiscGenics' Cell Therapy for Disc D...

SALT LAKE CITY and TOKYO, Jan. 7, 2020 /PRNewswire-AsiaNet/ -- DiscGenics, Inc. ( https://www.discgenics.com/ ), a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, toda...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660